Company intelligence / Profile preview

Kalbe Farma

Jakarta, Daerah Khusus Ibukota Jakarta Raya, Indonesiakalbe.co.id ↗
Ownership
Private
Employees
~16235
Development stage
Commercial
01

Overview

Kalbe Farma is the largest publicly-listed pharmaceutical company in Southeast Asia with a diverse portfolio of marketed products across prescription pharmaceuticals, consumer health, nutritionals, and distribution and logistics divisions.

Therapeutic areas
OncologyOphthalmologyImmunologyWomen's HealthHematologyInfectious Diseases
Modalities
Small moleculesBiosimilarsMonoclonal antibodiesFusion proteinsColony-stimulating factorsInterferons
Industry
Biotech
02

Drug pipeline

2 assets

Rillus (Universitas Indonesia)

Unknown

1 more asset in the full pipeline.

03

Partnerships

Genexine Inc. (South Korea)GC Cell

Beyond the preview

Go deeper on Kalbe Farma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kalbe Farma.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call